EUVIMEDEUVIMED entdecken
Crossref

Benzofuranyl-pyrazole as a Novel Scaffold for In Vitro and In Vivo Potent Anticancer Therapeutics That Directly Disrupt the ‘Undruggable’ MYC Oncogene and Potentiate Immune Checkpoint Blockage

Liuqing Yang, Haojie Zuo, Mengdie Sha, Wenhu Zhan iD, Jiaming Li, Yulei Liu, Fang Fang, Yang Wang iD, Xiaodong Ma iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c01307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Liuqing Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China. Hauptthemen laut MEDLINE: Pyrazoles, Benzofurans, Antineoplastic Agents, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: University Natural Science Research Project of Anhui Province, Major Science and Technology Projects in Anhui Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting the 'undruggable' MYC oncogene remains a challenging objective. Despite substantial research efforts, a majority of MYC direct inhibitors discovered so far lack in vivo efficacy. Herein, benzofuranyl-pyrazole has been identified as a structurally novel scaffold directly disrupting MYC function. Among the final compounds, 15 displayed 10-fold enhanced antiproliferative activity over MYCi975, a well-established MYC inhibitor, against PC-3 cells. Besides, it exhibited low micromolar to submicromolar activities against 14 other neoplastic cell lines. Its direct perturbation of MYC function was confirmed by the obstruction of MYC/MAX interaction in Co-IP and AlphaLISA assays. Moreover, it decreased MYC thermal stability, triggered MYC degradation, and impaired expression of MYC-responsive luciferase. Notably, 15 potently delayed tumor growth and outperformed MYCi975 in a mouse allograft model, even when administered every other day. Meanwhile, it synergized with a small-molecule immune checkpoint inhibitor in vivo, highlighting its potential application in immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazolesBenzofuransAntineoplastic AgentsImmune Checkpoint InhibitorsProto-Oncogene Proteins c-mycAnimalsHumansMiceCell ProliferationCell Line, TumorStructure-Activity RelationshipDrug Screening Assays, Antitumor

Substanzen

PyrazolesBenzofuransAntineoplastic AgentsImmune Checkpoint InhibitorsProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
  • iCarbonX (Shenzhen) Co., Ltd., Shenzhen 518000, China.
  • Department of Medicinal Chemistry, Anhui Academy of Chinese Medicine, Hefei 230012, China.
  • Anhui Province Key Laboratory of Bioactive Natural Products, Hefei 230012, China.

ORCID-Profile: Wenhu Zhan, Yang Wang, Xiaodong Ma

Förderung

  • University Natural Science Research Project of Anhui Province
  • Major Science and Technology Projects in Anhui Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Anhui Province

Zitieren

APA

Yang, L., Zuo, H., Sha, M., Zhan, W., Li, J., Liu, Y., Fang, F., Wang, Y., & Ma, X. (2025). Benzofuranyl-pyrazole as a Novel Scaffold for In Vitro and In Vivo Potent Anticancer Therapeutics That Directly Disrupt the ‘Undruggable’ MYC Oncogene and Potentiate Immune Checkpoint Blockage. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01307

Vancouver

Yang L, Zuo H, Sha M, Zhan W, Li J, Liu Y, et al. Benzofuranyl-pyrazole as a Novel Scaffold for In Vitro and In Vivo Potent Anticancer Therapeutics That Directly Disrupt the ‘Undruggable’ MYC Oncogene and Potentiate Immune Checkpoint Blockage. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01307

BibTeX
@article{Yang2025,
  author = {Yang, Liuqing and Zuo, Haojie and Sha, Mengdie and Zhan, Wenhu and Li, Jiaming and Liu, Yulei and Fang, Fang and Wang, Yang and Ma, Xiaodong},
  title = {Benzofuranyl-pyrazole as a Novel Scaffold for In Vitro and In Vivo Potent Anticancer Therapeutics That Directly Disrupt the ‘Undruggable’ MYC Oncogene and Potentiate Immune Checkpoint Blockage},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c01307}
}
Kostenlos starten →